Gangqiang Y. Guo

Wenzhou Key Laboratory Of Cancer Related Pathogens And Immunity
Wenzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 43 publications

METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis.

METTL3-targeted intervention on nuclear factors RORA/RORγt suppresses pathogenic T helper 17 cell differentiation and alleviates kidney damage in lupus nephritis.

Journal: Kidney international

Published: September 25, 2025

5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.

5-Hydroxymethylcytosine in circulating cell-free DNA as a potential diagnostic biomarker for SLE.

Journal: Lupus science & medicine

Published: June 17, 2024

Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study.

Multi‑omics identification of a novel signature for serous ovarian carcinoma in the context of 3P medicine and based on twelve programmed cell death patterns: a multi-cohort machine learning study.

Journal: Molecular medicine (Cambridge, Mass.)

Published: June 04, 2024

RNA epigenetic modifications in digestive tract cancers: Friends or foes.

RNA epigenetic modifications in digestive tract cancers: Friends or foes.

Journal: Pharmacological research

Published: April 24, 2024

Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk.

Multi-omics analysis uncovered systemic lupus erythematosus and COVID-19 crosstalk.

Journal: Molecular medicine (Cambridge, Mass.)

Published: April 01, 2024

Fatty acid metabolism-related lncRNA prognostic signature for serous ovarian carcinoma.

Fatty acid metabolism-related lncRNA prognostic signature for serous ovarian carcinoma.

Journal: Epigenomics

Published: February 15, 2024

Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.

Identification of potential novel N6-methyladenosine effector-related lncRNA biomarkers for serous ovarian carcinoma: a machine learning-based exploration in the framework of 3P medicine.

Journal: Frontiers in pharmacology

Published: December 07, 2023

Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis.

Emerging roles of the epitranscriptome in parasitic protozoan biology and pathogenesis.

Journal: Trends in parasitology

Published: November 12, 2023

Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation.

Novel mitophagy inducer alleviates lupus nephritis by reducing myeloid cell activation and autoantigen presentation.

Journal: Kidney international

Published: January 15, 2023

Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer.

Molecular characteristics, oncogenic roles, and relevant immune and pharmacogenomic features of NEK2 in gastric cancer.

Journal: International immunopharmacology

Published: November 22, 2022

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.

RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.

Journal: Wiley interdisciplinary reviews. RNA

Published: November 01, 2022

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma.

Four Types of RNA Modification Writer-Related lncRNAs Are Effective Predictors of Prognosis and Immunotherapy Response in Serous Ovarian Carcinoma.

Journal: Frontiers in immunology

Published: January 27, 2022

Showing 1-12 of 43

Last Updated: 09/26/2026